으름덩굴 추출물을 함유하는 비만증 치료 및 예방용 조성물
    1.
    发明公开
    으름덩굴 추출물을 함유하는 비만증 치료 및 예방용 조성물 有权
    含有Akebiae Caulis提取物的组合物,用于预防和治疗肥胖症

    公开(公告)号:KR1020120130477A

    公开(公告)日:2012-12-03

    申请号:KR1020110048433

    申请日:2011-05-23

    Abstract: PURPOSE: A composition containing Lardizabalaceae extract is provided to suppress adipocyte differentiation and to prevent and treat obesity. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity contains Lardizabalaceae extract as an active ingredient. The Lardizabalaceae extract is prepared from Lardizabalaceae leaves, stems, or whole plant using water, low carbon number alcohol of 1-4 carbon atoms, or a mixture thereof. A health functional food for preventing and treating obesity contains the Lardizabalaceae extract as an active ingredient. The health functional food is powder, granules, tablets, capsules, or drinks. A food additive for preventing and treating obesity contains the Lardizabalaceae extract as a main ingredient.

    Abstract translation: 目的:提供含有Lardizabalaceae提取物的组合物以抑制脂肪细胞分化和预防和治疗肥胖。 构成:用于预防和治疗肥胖症的药物组合物含有Lardizabalaceae提取物作为活性成分。 Lardizabalaceae提取物使用水,1-4碳原子的低碳数醇或其混合物从Lardizabalaceae叶,茎或全植物制备。 用于预防和治疗肥胖症的健康功能食品含有Lardizabalaceae提取物作为活性成分。 健康功能食品是粉末,颗粒,片剂,胶囊或饮料。 用于预防和治疗肥胖症的食品添加剂含有Lardizabalaceae提取物作为主要成分。

    발효울금 분말을 함유한 알코올성 간손상 보호용 조성물
    3.
    发明公开
    발효울금 분말을 함유한 알코올성 간손상 보호용 조성물 无效
    包含发酵的CURCUMA LONGA L的粉末的组合物,用于保护酒精性肝脏损伤

    公开(公告)号:KR1020140026737A

    公开(公告)日:2014-03-06

    申请号:KR1020120092198

    申请日:2012-08-23

    Abstract: The present invention relates to a composition containing fermented Curcuma longa powder for treating alcoholic liver damage. The fermented Curcuma longa powder of the present invention is obtained by fermenting materials for the fermented Curcuma longa powder using Aspergillus oryzae, and sterilizing and drying the materials, and shows a strong liver damage control function in an alcoholic liver damage model. The composition can be practically used for treatment and prevention food for alcoholic liver damage, medical products, and outer medical products using the fermented Curcuma longa powder.

    Abstract translation: 本发明涉及含有用于治疗酒精性肝损伤的发酵姜黄粉的组合物。 本发明的发酵姜黄粉是通过使用米曲霉发酵的姜黄发酵材料进行发酵而得到的,对该材料进行灭菌干燥,在酒精性肝损伤模型中显示出强烈的肝损伤控制功能。 该组合物可用于治疗和预防酒精性肝损伤的食物,医疗产品和使用发酵的姜黄粉的外用医药产品。

    해당화 추출물을 유효성분으로 함유하는 운동성 육체적 스트레스 관련 질환의 치료 및 예방을 위한 조성물
    4.
    发明公开
    해당화 추출물을 유효성분으로 함유하는 운동성 육체적 스트레스 관련 질환의 치료 및 예방을 위한 조성물 有权
    包含ROSA RUGOSA提取物或治疗物理应激性疾病的组合物和功能性食品

    公开(公告)号:KR1020140046233A

    公开(公告)日:2014-04-18

    申请号:KR1020120112449

    申请日:2012-10-10

    CPC classification number: A61K36/738 A23V2200/322 A61K2236/331

    Abstract: The present invention relates to a composition comprising an extract of Rosa rugosa stem and leaves and, more specifically, to a pharmaceutical composition and a functional health food for suppressing, preventing, and alleviating stress-related diseases caused by a lack of sleep which comprises a powder or an extract obtainable by extracting and concentrating Rosa rugosa stem and leaves by using various solvents. The extract of Rosa rugosa stem and leaves according to the present invention is confirmed to have excellent effects for increasing survival rate, reducing drowsing, reducing cortisol content, and protecting nerve cells against sleep deprivation in rats.

    Abstract translation: 本发明涉及一种组合物,其包含罗莎蔷薇茎和叶的提取物,更具体地涉及用于抑制,预防和减轻由睡眠不足引起的与压力有关的疾病的药物组合物和功能保健食品,其包含 粉末或通过使用各种溶剂提取和浓缩罗莎蔷薇茎叶而获得的提取物。 确认本发明的罗莎芦苇提取物对提高存活率,降低呕吐,降低皮质醇含量,保护神经细胞免受大鼠睡眠剥夺的作用具有优异的效果。

    복합생약 추출물을 함유하는 숙취해소 및 간질환의 치료 및 예방용 조성물
    7.
    发明授权
    복합생약 추출물을 함유하는 숙취해소 및 간질환의 치료 및 예방용 조성물 有权
    组合物,其包含用于预防和治疗宿醉或肝脏疾病的联合生药的提取物

    公开(公告)号:KR101383146B1

    公开(公告)日:2014-04-09

    申请号:KR1020120052744

    申请日:2012-05-18

    Inventor: 김용재 오규철

    Abstract: 본 발명은 갈화(칡꽃), 상심(오디), 오미자, 상엽(뽕잎), 지구자(헛개나무열매), 국호(국화), 진피(귤껍질), 맥문동 및 당삼(만삼)으로 구성된 복합생약 추출물을 유효성분으로 함유하는 간 질환 및 숙취의 예방 및 치료를 위한 조성물에 관한 것으로, 본 발명의 추출물은
    in

    vitro 상에서 ADH 및 ALDH 효소 수준을 억제하고
    in

    vivo 상에서는 Ethanol과 Acetaldehyde의 혈중 농도를 유의적으로 억제하는 숙취해소 및 간질환에 대한 치료 효과를 확인함으로써, 숙취해소 및 간질환의 예방 및 치료용 약학조성물에 이용될 수 있다.

    유자 추출물을 포함하는 전립선 비대증 예방 및 치료를 위한 조성물
    8.
    发明公开
    유자 추출물을 포함하는 전립선 비대증 예방 및 치료를 위한 조성물 有权
    一种包含CITRUS JUNOS提取物以预防和治疗BENIGN PROSTATIC HYPERPLASIA的组合物

    公开(公告)号:KR1020140020433A

    公开(公告)日:2014-02-19

    申请号:KR1020120086755

    申请日:2012-08-08

    CPC classification number: A61K36/752 A61K2236/331 A61K2236/333

    Abstract: The present invention relates to a composition containing an extract of Citrus junos for preventing and treating benign prostatic hyperplasia. The extract of Citrus junos shows high survival rate of cells with high cytotoxicity among prostatic carcinoma cells, inhibitory activity for 5-alpha- reductase type 1 and 2 extracted from liver of SD rat grown for 12 weeks in which prostatomegaly is induced, a control effect of 5RD activity in 5RD type 2 overexpressed prostate cells, and a control effect of mRNA of PSA. The extract of Citrus junos also shows the significant reduction of DHT change in a prostatomegaly induction experiment using rats to be usefully applied to a pharmaceutical composition for preventing and treating benign prostatic hyperplasia and health functional food. [Reference numerals] (AA,DD) Citrus junos(water); (BB,EE) Citrus junos(20% alcohol); (CC,FF) Citrus junos(80% alcohol)

    Abstract translation: 本发明涉及含有用于预防和治疗良性前列腺增生的柑橘属杜鹃花提取物的组合物。 柠檬提取物表现出前列腺癌细胞细胞毒性高的细胞存活率高,生长前列腺增生12周的SD大鼠肝脏提取的5型α-还原酶1型和2型的抑制活性为对照组, 的5RD 2型过表达前列腺细胞中的5RD活性,以及​​PSA的mRNA的控制作用。 Citrus junos的提取物还显示使用大鼠有用地应用于预防和治疗良性前列腺增生和健康功能性食物的药物组合物的前列腺肥大诱导实验中DHT变化的显着降低。 (参考号)(AA,DD)柑橘属(水); (BB,EE)Citrus junos(20%酒精); (CC,FF)柑橘类(80%酒精)

    해당화 추출물을 유효성분으로 함유하는 수면부족으로 인한 스트레스 관련 질환의 치료 및 예방을 위한 조성물
    9.
    发明公开
    해당화 추출물을 유효성분으로 함유하는 수면부족으로 인한 스트레스 관련 질환의 치료 및 예방을 위한 조성물 无效
    包含ROSA RUGOSA的提取物的组合物和功能食品,预防或治疗由休眠导致的紧张性疾病引起的疾病

    公开(公告)号:KR1020130090936A

    公开(公告)日:2013-08-16

    申请号:KR1020120012067

    申请日:2012-02-07

    Abstract: PURPOSE: A composition for preventing and treating diseases caused by lack of sleep is provided to prevent nerve cell damage due to a stress inducer in nerve cells (SH-SY5), to suppress stress, and to obtain a pharmaceutical composition or a health food for suppressing, treating, preventing, and alleviating diseases caused by stress. CONSTITUTION: A pharmaceutical composition for preventing and treating stress-related diseases contains a Rosa rugosa extract as an active ingredient. The extract is prepared from Rosa rugosa stems, flowers, roots, or plants using water, spirit, C1-C4 alcohols, or a mixture thereof. The stress-related diseases are depression, insomnia, hypersomnia, hypnolepsy, circadian rhythm sleep disorder, incubus, or somnambulism. [Reference numerals] (AA) Rosa rugosa

    Abstract translation: 目的:提供一种用于预防和治疗由睡眠不足引起的疾病的组合物,以防止由于神经细胞(SH-SY5)中的应激诱导剂引起的神经细胞损伤,抑制应激,并获得药物组合物或保健食品 抑制,治疗,预防和缓解压力引起的疾病。 构成:用于预防和治疗应激相关疾病的药物组合物含有罗莎玫瑰提取物作为活性成分。 使用水,精油,C1-C4醇或其混合物从罗莎蔷薇茎,花,根或植物制备提取物。 压力相关的疾病是抑郁症,失眠症,睡眠过多,hypnoleys,昼夜节律睡眠障碍,孵化或嗜睡症。 (附图标记)(AA)罗莎

Patent Agency Ranking